Physician Photo

Nicte I. Mejia-Gonzalez, MD

Assistant Professor, Department of Neurology

Director, MGH Neurology Diversity and Community Outreach Initiatives

Dr. Mejia's clinical practice centers on caring for patients with Parkinson disease and other movement disorders. Her research aims to help all patients receive the best possible Neurology care and clinical outcomes.

  • Phone: 855-644-6387
Departments
Department of Neurology
Clinical Interests
Parkinson's disease; parkinsonism; atypical parkinsonism
Progressive supranuclear palsy; multiple systems atrophy
Tremor; essential tremor; medication-related tremor
Chorea; Huntington disease; Wilson disease
Dystonia, myoclonus, ataxia
Tardive dyskinesia
Gait disorders
Medication-related movement disorders
Psychogenic movement disorders
Other movement disorders
Locations
Boston: Massachusetts General Hospital
Medical Education
MD, Escuela de Medicina Ignacio Santos
Residency, Brigham and Women's Hospital
Fellowship, Massachusetts General Hospital
Board Certifications
Neurology, American Board of Psychiatry and Neurology
Gender
Female
Patient Gateway
Yes, learn more
Foreign Languages
French
Spanish
Patient Age Group
Adult
Accepting New Patients
Yes

Biography

Nicte I. Mejia, MD MPH is Assistant Professor of Neurology at Massachusetts General Hospital and Harvard Medical School, and the MGH Neurology Director of Diversity and Community Outreach Initiatives. Dr. Mejia was born in Guatemala of Mexican and Salvadorian parents. She obtained Neurology and Movement Disorders subspecialty training at Massachusetts General Hospital and Brigham & Women's Hospital, as well as a degree of Master of Public Health from Harvard University. Dr. Mejia cares for a culturally diverse group of patients with Parkinson disease and other movement disorders. She conducts health services research to develop creative, collaborative, and scientifically-founded interventions that could improve neurology care globally. Her research is particularly important for minority and non-English speaking patients as they often face greater challenges towards obtaining the best possible function and quality of life. Dr. Mejia's research has been funded by the American Academy of Neurology Foundation, the Rappaport Foundation, Harvard Medical School, and Harvard School of Public Health. 

ResearchDr. Mejia seeks to provide a scientific framework for interventions to improve the care and clinical outcomes for Parkinson disease patients and others affected by neurologic disease. She is particularly focused on addressing racial and social inequalities. A career in neurology, subspecialty in movement disorders, practical experience conducting movement disorders clinical trials, and public health research training solidify her capability and motivation to successfully pursue this research. Current projects include an analysis of U.S.-wide data on the effects of race, ethnicity, and socioeconomic status on access to neurologic treatments such as deep brain stimulation for Parkinson disease. She has received funding from the American Academy of Neurology, the Rappaport Foundation, Harvard Medical School, and Harvard School of Public Health.

Publications

View my most recent publications at PubMed

Mejia NI, Jankovic J. Secondary tics and tourettism. Rev Bras Psiquiatr 2005
Mejia NI, Vuong KD, Jankovic J. Long-term botulinum toxin efficacy, safety, and immunogenicity. Mov Disord 2005
Mejia NI, Jankovic J. Metoclopramide-induced tardive dyskinesia in an infant. Mov Disord 2005
Kenney C, Hunter C, Mejia N, Jankovic J. Is history of depression a contraindication to treatment with tetrabenazine? Clin Neuropharmacol 2006
Jankovic J, Mejia NI. Tics associated with other disorders. Adv Neurol 2006
Kenney C, Hunter CB, Mejia NI, Jankovic J. Tetrabenazine in the treatment of Tourette syndrome. J Ped Neurol 2007
Deng H, Le WD, Hunter CB, Mejia N, Xie WJ, Jankovic J. A family with Parkinson disease, essential tremor, bell palsy, and parkin mutations. Arch Neurol 2007
Ondo WG, Mejia NI, Hunter CB. A pilot study of the clinical efficacy and safety of memantine for Huntington disease. Parkinsonism Relat Disord 2007
Kenney C, Diamond A, Mejia N, et al. Distinguishing psychogenic and essential tremor. J Neurol Sci 2007
Mejia NI, Park S, et al. Pearls and Oy-sters: reversible iatrogenic Balint syndrome. Neurology 2008
Mejia NI, Pless M. Downbeat nystagmus in Wernicke encephalopathy. Neuro-opthal 2009
Mejia NI, Jankovic J. Tardive dyskinesia and withdrawal emergent syndrome in children. Expert Rev Neurother 2010
Mejia NI, Nardin R. Dying young: eliminating racial disparities in neuromuscular disease outcomes. Neurology 2010

In General awards and honors: March 22, 2013

In General awards and honors: March 22, 2013

Neurology Associates
15 Parkman Street
Boston, MA 02114-3117

Phone: 855-644-6387
Phone 2: 617-726-5532
Fax: 617-726-4101

  • © 2013 Massachusetts General Hospital
  • 617-726-2000
  • TDD: 617-724-8800

Site Map

  • Partners Healthcare
  • Harvard Medical School
  • Massachusetts General Physicians Organization
  • MassGeneral Hospital for Children
  • Individual Care, Global Impact: The Campaign for the Third Century of MGH Medicine
  • Proto